Class IIOngoingD-0694-2026
Drug recall · July 8, 2026
TRIPENICOL S Antifungal Solution recall
Why: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ (37.5 mL) bottle, Manufactured For: Trifluent Pharma, LLC, San Antonio, TX 78213, NDC 73352-550-01.
- Lots / codes
Lot #BL3411R, Exp 6/8/2027
- Quantity
- 144 bottles
- Company
- Blaine Labs Inc, Santa Fe Springs, CA
- Distribution
- Nationwide in the USA
- Initiated
- April 8, 2026 · Voluntary: Firm initiated
- Classified
- July 16, 2026
- Reported
- July 8, 2026
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IOngoingJul 8, 2026Revitaderm Wound Care GelBlaine Labs Inc · D-0692-2026Class IIOngoingJul 8, 2026TRIFLUENT PHARMA TRIDERGEL Wound Care GelBlaine Labs Inc · D-0693-2026Class IIOngoingJul 8, 2026TERPENICOL Antifungal CreamBlaine Labs Inc · D-0695-2026Class IIOngoingJul 8, 2026vite20 Antifungal CreamBlaine Labs Inc · D-0696-2026Class IIOngoingJul 8, 2026TERPENICOL Antifungal SolutionBlaine Labs Inc · D-0697-2026Class IIOngoingJul 8, 2026Fungal Fusion ERADICATION SolutionBlaine Labs Inc · D-0698-2026Class IIOngoingJul 8, 2026Revitaderm Wound CareBlaine Labs Inc · D-0699-2026
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.